<?xml version='1.0' encoding='iso-8859-1'?>
<PASBIO>
    <framesest>
        <predicate lemma="decrease">
            <roleset id="decrease.02" name="" wordnet="1">
                <roles>
                    <role n="0" descr="theme&#10;" />
                    <role n="2" descr="amount decreased &#09;&#09;&#09;&#10;" />
                    <role n="1" descr="location&#10;" />
                </roles>
                <example src="EGRAM" no="0">
					<text>Concomitantly, acetylcholine levels is able to decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="0">
					<text>Concomitantly, acetycoline levels are able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">37.8%</arg>
					<arg n="2">lead animals treated with lead</arg>
				</example>
				<example src="EGRAM" no="1">
					<text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">37.8%</arg>
					<arg n="2">lead animals treated as lead</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>Concomitantly, acetylcholine levels may have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="2">
					<text>Concomitantly, acetycoline levels may have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">37.8%</arg>
					<arg n="2">lead animals treated with lead</arg>
				</example>
				<example src="EGRAM" no="3">
					<text>Concomitantly, acetycoline levels could decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">37.8%</arg>
					<arg n="2">lead animals treated as lead</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>Concomitantly, acetylcholine levels decreases by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="4">
					<text>Concomitantly, acetycoline levels decreases by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>Concomitantly, acetycoline levels decreased in 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="5">
					<text>Concomitantly, acetycoline levels decreased by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>Concomitantly, acetylcholine levels decreased by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="6">
					<text>Concomitantly, acetycoline levels have decreased by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="7">
					<text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>Concomitantly, acetylcholine levels may have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="8">
					<text>Concomitantly, acetycoline levels may have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>Concomitantly, acetylcholine levels may decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="9">
					<text>Concomitantly, acetycoline levels can decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>Concomitantly, acetycoline levels was able to decrease in 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="10">
					<text>Concomitantly, acetycoline levels were able to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>Concomitantly, it was predicted that acetycoline levels would decrease in 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="11">
					<text>Concomitantly, it was predicted that acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>Concomitantly, it was shown that acetycoline levels decreases by 37.8% in lead animals treated with lead decrease to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="12">
					<text>Concomitantly, acetycoline levels was shown to decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>Concomitantly, acetylcholine levels will decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="13">
					<text>Concomitantly, acetycoline levels will decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>Concomitantly, acetylcholine levels would have decreased by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="14">
					<text>Concomitantly, acetycoline levels will have decreased in 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>Concomitantly, acetylcholine levels would decrease by 37.8% in lead animals treated with lead compared to controls.</text>
					<arg n="0">acetylcholine levels</arg>
					<arg n="1">lead animals treated with lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="15">
					<text>Concomitantly, acetycoline levels would decrease by 37.8% in lead animals treated as lead compared to controls.</text>
					<arg n="0">acetycoline levels</arg>
					<arg n="1">lead animals treated as lead</arg>
					<arg n="2">37.8%</arg>
				</example>
				<example src="EGRAM" no="16">
					<text>In addition, CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
				</example>
				<example src="EGRAM" no="16">
					<text>In addition, the CD3 expression has the ability to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
				</example>
				<example src="EGRAM" no="17">
					<text>Also, is the CD3 statement shown to be decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
				</example>
				<example src="EGRAM" no="17">
					<text>In addition, the CD3? expression is decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
				</example>
				<example src="EGRAM" no="18">
					<text>In addition, CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
				</example>
				<example src="EGRAM" no="18">
					<text>In addition, the CD3 expression was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent (Fig.2B) way.</text>
				</example>
				<example src="EGRAM" no="19">
					<text>In addition, the expression of CD3? can be decreased by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3?</arg>
				</example>
				<example src="EGRAM" no="19">
					<text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="20">
					<text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>In addition, CD3 expression could decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3 expression</arg>
				</example>
				<example src="EGRAM" no="21">
					<text>In addition, CD3? expression could decrease by mixing normal T cells with TBM-M?s in a number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>In addition, the expression of CD3? expression decreases with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="22">
					<text>In addition, CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>In addition, the CD3? expression decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="23">
					<text>In addition, CD3? expression has decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>In addition, CD3? expression is able to decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="24">
					<text>In addition, CD3 expression? is able to decrease by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3 expression?</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>In addition, the expression of CD3? is decreasing by the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3?</arg>
				</example>
				<example src="EGRAM" no="25">
					<text>In addition, it is decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M? depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="26">
					<text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="27">
					<text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="27">
					<text>In addition, CD3? expression may have decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="28">
					<text>In addition, CD3? expression can decrease with normal T-cell blending with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="28">
					<text>In addition, CD3? expression can decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="29">
					<text>In addition, CD3? expression was able to decrease by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="29">
					<text>In addition, CD3? expression could be decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="30">
					<text>In addition, the expression CD3? was decrease by mixing normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3?</arg>
				</example>
				<example src="EGRAM" no="30">
					<text>In addition, it has been decrease that CD3? expression decreases by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="31">
					<text>In addition, the expression of CD3? will decrease with the mixture of normal T cells with TBM-M?s depending on cell number (Fig.2B).</text>
					<arg n="0">CD3?</arg>
				</example>
				<example src="EGRAM" no="31">
					<text>In addition, CD3? expression will decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="32">
					<text>In addition, CD3? expression will have decreased by mixing normal T cells with TBM-M?s depending on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="32">
					<text>In addition, CD3? expression has been decreased by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="33">
					<text>In addition, CD3? expression would decrease by mixing normal T cells with TBM-M?s in a way dependent on the number of cells (Fig.2B).</text>
					<arg n="0">CD3? expression</arg>
				</example>
				<example src="EGRAM" no="33">
					<text>In addition, CD3 expression? would decrease with the mixture of normal T cells with TBM-M?s in a cellular number-dependent manner (Fig.2B).</text>
					<arg n="0">CD3 expression?</arg>
				</example>
				<example src="EGRAM" no="34">
					<text>Instead, GP may have decreased by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="34">
					<text>In contrast, PG may have decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>Instead, PG can decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in people with little or no increase in plasma cytrullin concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="35">
					<text>In contrast, GP may decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>In contrast, GP may decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="36">
					<text>In contrast, PG could decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>Instead, GP decreased a reduction in only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="37">
					<text>In contrast, PG decreased a reduction in only in 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2">12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="38">
					<text>In contrast, GP is able to decrease only only by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="38">
					<text>By contrast, GP is able to decrease only by  12.4% +/-3.9%  (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9% </arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>In contrast, PG is found to decrease only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="39">
					<text>Instead, PG is found to decrease only by 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="2">12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="40">
					<text>By contrast, GP is predicted that only  decreased by  12.4% +/-3.9%  (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9% </arg>
					<arg n="M-ADV">only </arg>
				</example>
				<example src="EGRAM" no="40">
					<text>In contrast, GP is predicted that only decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="41">
					<text>In contrast, PG showed that only decreased by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="41">
					<text>In contrast, PG showed that only decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>Instead, GP may have decreased by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="42">
					<text>In contrast, PG may have decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>decreaseIdecreasendecreasesdecreasetdecreaseedecreaseadecreaseddecrease,decrease decreaseGdecreasePdecrease decreasecdecreaseadecreasendecrease decreaseodecreasendecreaseldecreaseydecrease decreaseddecreaseedecreasecdecreaserdecreaseedecreaseadecreasesdecreaseedecrease decreasebdecreaseydecrease decrease decrease1decrease2decrease.decrease4decrease%decrease decrease+decrease/decrease-decrease3decrease.decrease9decrease%decrease decrease decrease(decrease1decrease.decrease9decrease7decrease decrease+decrease/decrease-decrease0decrease.decrease1decrease3decrease decreasetdecreaseodecrease decrease1decrease.decrease7decrease3decrease decrease+decrease/decrease-decrease0decrease.decrease1decrease3decrease decreasemdecreasegdecrease/decreasekdecreasegdecrease/decreasemdecreaseidecreasendecrease;decrease decreasendecreaseodecreasetdecrease decreasesdecreaseidecreasegdecreasendecreaseidecreasefdecreaseidecreasecdecreaseadecreasendecreasetdecrease decrease[decreaseNdecreaseSdecrease]decrease)decrease decreaseidecreasendecrease decreasetdecreasehdecreaseodecreasesdecreaseedecrease decreasewdecreaseidecreasetdecreasehdecrease decreaseldecreaseidecreasetdecreasetdecreaseldecreaseedecrease decreaseodecreaserdecrease decreasendecreaseodecrease decreaseidecreasendecreasecdecreaserdecreaseedecreaseadecreasesdecreaseedecrease decreaseidecreasendecrease decreasepdecreaseldecreaseadecreasesdecreasemdecreaseadecrease decreasecdecreaseidecreasetdecreaserdecreaseudecreaseldecreaseldecreaseidecreasendecreaseedecrease decreasecdecreaseodecreasendecreasecdecreaseedecreasendecreasetdecreaserdecreaseadecreasetdecreaseidecreaseodecreasendecrease.decrease</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9% </arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="43">
					<text>In contrast, G may decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">G</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>Instead, PG can decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="44">
					<text>In contrast, PG may decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>decreasesIdecreasesndecreases decreasescdecreasesodecreasesndecreasestdecreasesrdecreasesadecreasessdecreasestdecreases,decreases decreasesPdecreasesGdecreases decreasesodecreasesndecreasesldecreasesydecreases decreasesddecreasesedecreasescdecreasesrdecreasesedecreasesadecreasessdecreasesedecreasessdecreases decreasesbdecreasesydecreases decreases decreases1decreases2decreases.decreases4decreases%decreases decreases+decreases/decreases-decreases3decreases.decreases9decreases%decreases decreases(decreases1decreases.decreases9decreases7decreases decreases+decreases/decreases-decreases0decreases.decreases1decreases3decreases decreasestdecreasesodecreases decreases1decreases.decreases7decreases3decreases decreases+decreases/decreases-decreases0decreases.decreases1decreases3decreases decreasesmdecreasesgdecreases/decreaseskdecreasesgdecreases/decreasesmdecreasesidecreasesndecreases;decreases decreasesndecreasesodecreasestdecreases decreasessdecreasesidecreasesgdecreasesndecreasesidecreasesfdecreasesidecreasescdecreasesadecreasesndecreasestdecreases decreases[decreasesNdecreasesSdecreases]decreases)decreases decreasesidecreasesndecreases decreasespdecreasesedecreasesodecreasespdecreasesldecreasesedecreases decreaseswdecreasesidecreasestdecreaseshdecreases decreasesldecreasesidecreasestdecreasestdecreasesldecreasesedecreases decreasesodecreasesrdecreases decreasesndecreasesodecreases decreasesidecreasesndecreasescdecreasesrdecreasesedecreasesadecreasessdecreasesedecreases decreasesidecreasesndecreases decreasespdecreasesldecreasesadecreasessdecreasesmdecreasesadecreases decreasescdecreasesidecreasestdecreasesrdecreasesudecreasesldecreasesldecreasesidecreasesndecreases decreasescdecreasesodecreasesndecreasescdecreasesedecreasesndecreasestdecreasesrdecreasesadecreasestdecreasesidecreasesodecreasesndecreases.decreases</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="45">
					<text>decreasesIdecreasesndecreases decreasescdecreasesodecreasesndecreasestdecreasesrdecreasesadecreasessdecreasestdecreases,decreases decreasesPdecreasesGdecreases decreasestdecreaseshdecreasesedecreases decreasesodecreasesndecreasesldecreasesydecreases decreasesddecreasesedecreasescdecreasesrdecreasesedecreasesadecreasessdecreasesedecreasessdecreases decreasesbdecreasesydecreases decreases decreases1decreases2decreases.decreases4decreases%decreases decreases+decreases/decreases-decreases3decreases.decreases9decreases%decreases decreases(decreases1decreases.decreases9decreases7decreases decreases+decreases/decreases-decreases0decreases.decreases1decreases3decreases decreasestdecreasesodecreases decreases1decreases.decreases7decreases3decreases decreases+decreases/decreases-decreases0decreases.decreases1decreases3decreases decreasesmdecreasesgdecreases/decreaseskdecreasesgdecreases/decreasesmdecreasesidecreasesndecreases;decreases decreasesndecreasesodecreasestdecreases decreasessdecreasesidecreasesgdecreasesndecreasesidecreasesfdecreasesidecreasescdecreasesadecreasesndecreasestdecreases decreases[decreasesNdecreasesSdecreases]decreases)decreases decreasesidecreasesndecreases decreasespdecreasesedecreasesodecreasespdecreasesldecreasesedecreases decreaseswdecreasesidecreasestdecreaseshdecreases decreasesldecreasesidecreasestdecreasestdecreasesldecreasesedecreases decreasesodecreasesrdecreases decreasesndecreasesodecreases decreasesidecreasesndecreasescdecreasesrdecreasesedecreasesadecreasessdecreasesedecreases decreasesidecreasesndecreases decreasespdecreasesldecreasesadecreasessdecreasesmdecreasesadecreases decreasescdecreasesidecreasestdecreasesrdecreasesudecreasesldecreasesldecreasesidecreasesndecreases decreasescdecreasesodecreasesndecreasescdecreasesedecreasesndecreasestdecreasesrdecreasesadecreasestdecreasesidecreasesodecreasesndecreases.decreases</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>Instead, PG was found to decrease 12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) A1 (in people with little or no increase in plasma cytrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="2">12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="46">
					<text>In contrast, PG was found to decrease  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; non-significant [NS]) A1 (in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>Instead, GP was decreased by decreased only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="47">
					<text>In contrast, PG was predicted for only decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>In contrast, GP was demonstrated by only decreased by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="48">
					<text>In contrast, GP was decreased by the reduction of only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1"> 12.4% +/-3.9%</arg>
					<arg n="2">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>Instead, GP would have decreased in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="49">
					<text>Instead, GP would have decreased by  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in those with little or no increase in plasma citrulline concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in those with little or no increase in plasma citrulline concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>In contrast, PG will decrease only only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="50">
					<text>In contrast, GP will only decrease only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; no significant [NS]) in people with small or no increase in plasma citrullin concentration.</text>
					<arg n="0">GP</arg>
					<arg n="1">in people with small or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>Instead, PG would only decrease only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; not significant [NS]) in people with little or no increase in plasma cytrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma cytrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
				<example src="EGRAM" no="51">
					<text>In contrast, PG would only decrease only in  12.4% +/-3.9% (1.97 +/-0.13 to 1.73 +/-0.13 mg/kg/min; it was not significant [NS]) in people with little or no increase in plasma citrullin concentration.</text>
					<arg n="0">PG</arg>
					<arg n="1">in people with little or no increase in plasma citrullin concentration</arg>
					<arg n="2"> 12.4% +/-3.9%</arg>
					<arg n="M-ADV">only</arg>
				</example>
			</roleset>
        </predicate>
    </framesest>
</PASBIO>